WINTON GROUP Ltd

Position in CYTK — Cytokinetics Inc

CIK 1612063 LONDON, X0

Position in CYTK

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$774,206

-$156,167 QoQ

Shares Held

9,088

-67.7% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#278

of 477 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. CYTK ranks #27 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	254,408	$28,839,690
2	FTRE	Fortrea Holdings Inc.	389,155	$6,771,297
3	EXEL	Exelixis, Inc.	99,834	$5,431,967
4	TECH	BIO-TECHNE Corp	67,227	$4,749,587
5	HALO	Halozyme Therapeutics, Inc.	60,348	$4,723,437
6	VKTX	Viking Therapeutics, Inc.	90,546	$3,532,199
7	ALNY	Alnylam Pharmaceuticals, Inc.	7,880	$2,372,116
8	TRVI	Trevi Therapeutics, Inc.	106,852	$1,992,789

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$774,206	9,088	-67.7%	Shares	Sole	2026-08-07
2025-06-30	$930,373	28,159	+16.1%	Shares	Sole	2025-08-14
2025-03-31	$974,808	24,255	+27.6%	Shares	Sole	2025-05-15
2024-12-31	$893,995	19,005	+94.0%	Shares	Sole	2025-02-12
2024-09-30	$517,176	9,795	-46.0%	Shares	Sole	2024-11-12
2024-06-30	$983,312	18,149	+3.1%	Shares	Sole	2024-08-09
2023-12-31	$1,469,090	17,596	+54.6%	Shares	Sole	2024-02-12
2023-03-31	$400,462	11,380	+9.6%	Shares	Sole	2023-05-12
2022-12-31	$475,611	10,380	+48.8%	Shares	Sole	2023-02-14
2022-09-30	$338,035	6,977	-4.1%	Shares	Sole	2022-11-10
2022-06-30	$285,795	7,274	+5.9%	Shares	Sole	2022-08-10
2021-12-31	$313,043	6,868	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.